FierceBiotech 2026年4月17日 A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
FierceBiotech 2026年4月17日 Small pools, big ideas: How the rare disease community is reimagining clinical trials
FierceBiotech 2026年4月16日 RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
FierceBiotech 2026年4月16日 Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech 2026年4月16日 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech 2026年4月16日 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
FierceBiotech 2026年4月16日 Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups
FierceBiotech 2026年4月16日 FDA advisory committee set to weigh taking action on certain unapproved peptides
FierceBiotech 2026年4月15日 Was Big Pharma’s ‘unusually aggressive’ M&A spree to blame for March IPO drought?
FierceBiotech 2026年4月15日 Spain sets up Boston-focused VC fund with goal of raising $200M for biotechs
FierceBiotech 2026年4月15日 Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech 2026年4月15日 Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS